Global Cord Blood Corporation (CO)
Stock Price:
$3.48 USD
-0.06 (-1.69%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
423.00M |
| Revenue (ttm) |
174.49M |
| Net Income (ttm) |
470.72M |
| Shares Out |
121.55M |
| EPS (ttm) |
0.29 |
| PE Ratio |
12.00 |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 19, 2020 |
| Last Price |
$3.48 |
| Previous Close |
$3.54 |
| Change ($) |
-0.06 |
| Change (%) |
-1.69% |
| Day's Open |
3.57 |
| Day's Range |
3.48 - 3.57 |
| Day's Volume |
48,700 |
| 52-Week Range |
2.54 - 5.79 |
More Stats
| Market Cap |
423.00M |
| Enterprise Value |
-358.41M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
121.55M |
| Float |
34.73M |
| EPS (basic) |
n/a |
| EPS (diluted) |
0.29 |
| FCF / Share |
0.71 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
8.33% |
| FCF Yield |
20.53% |
| Payout Ratio |
n/a |
| Shares Short |
280,105 |
| Short Ratio |
3.27 |
| Short % of Float |
0.81% |
| Beta |
0.50 |
| PE Ratio |
12.00 |
| Forward PE |
n/a |
| P/FCF Ratio |
4.87 |
| PS Ratio |
2.42 |
| PB Ratio |
0.71 |
| Revenue |
174.49M |
| Operating Income |
79.86M |
| Net Income |
470.72M |
| Free Cash Flow |
86.85M |
| Net Cash |
781.41M |
| Net Cash / Share |
6.43 |
| Gross Margin |
84.52% |
| Operating Margin |
45.77% |
| Profit Margin |
38.50% |
| FCF Margin |
49.77% |
| ROA |
5.13% |
| ROE |
13.28% |
| ROIC |
58.80% |
Key stats in USD, based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
15.0
Current: $3.48
High
15.0
Target: 15.00
*Average 12-month USD price target from 1 stock analysts.
Financial Performance
Financial numbers in millions CNY.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 1,221 | 987 | 937 | 760 | 663 | 635 | 573 | 526 | 380 | 340 |
| Revenue Growth | 23.79% | 5.34% | 23.26% | 14.63% | 4.39% | 10.87% | 8.88% | 38.28% | 12.06% | - |
| Gross Profit | 1,032 | 801 | 755 | 617 | 518 | 505 | 467 | 420 | 294 | 262 |
| Operating Income | 559 | 382 | 280 | 265 | 191 | 235 | 234 | 210 | 135 | 124 |
| Net Income | 471 | 291 | 237 | 126 | 90.97 | 107 | 132 | 112 | 132 | 91.70 |
| Shares Outstanding | 122 | 121 | 80.08 | 80.08 | 80.08 | 73.00 | 73.00 | 73.14 | 75.41 | 66.74 |
| Earnings Per Share | 3.87 | 2.40 | 1.99 | 1.59 | 1.25 | 1.36 | 1.60 | 1.49 | 1.79 | 1.31 |
| EPS Growth | 61.25% | 20.6% | 25.16% | 27.2% | -8.09% | -15% | 7.38% | -16.76% | 36.64% | - |
| Operating Cash Flow | 624 | 792 | 819 | 638 | 581 | 595 | 536 | 579 | 354 | 177 |
| Capital Expenditures | -16.06 | -30.21 | -66.69 | -24.42 | -16.48 | -37.78 | -150 | -226 | -42.76 | -20.67 |
| Free Cash Flow | 608 | 762 | 752 | 613 | 565 | 557 | 386 | 353 | 311 | 156 |
| Cash & Equivalents | 5,473 | 4,998 | 4,251 | 3,510 | 3,008 | 2,444 | 1,883 | 1,494 | 795 | 611 |
| Total Debt | 3.50 | - | - | 1,031 | 966 | 868 | 838 | 802 | 45.00 | 45.00 |
| Net Cash / Debt | 5,470 | 4,998 | 4,251 | 2,479 | 2,042 | 1,576 | 1,045 | 692 | 750 | 566 |
| Assets | 7,220 | 6,551 | 5,844 | 5,183 | 4,688 | 4,112 | 3,631 | 2,986 | 1,824 | 1,564 |
| Liabilities | 3,331 | 3,128 | 2,726 | 3,340 | 2,975 | 2,568 | 2,191 | 1,745 | 589 | 470 |
| Book Value | 3,882 | 3,417 | 3,113 | 1,838 | 1,709 | 1,538 | 1,435 | 1,237 | 1,203 | 1,071 |
Numbers in millions CNY, except per-share numbers.
Company Details
| Full Name |
Global Cord Blood Corporation |
| Country |
Hong Kong |
| Employees |
1,260 |
| CEO |
Ting Zheng |
Stock Information
| Ticker Symbol |
CO |
| Stock Exchange |
New York Stock Exchange |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NYSE: CO |
Description
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).